FDA 483 - Lonza Tampa LLC - September 29, 2023

Lonza Tampa LLC, a drug manufacturer, was cited for deficiencies in its quality control unit's procedures. The firm failed to thoroughly investigate cleaning residue failures by identifying a root cause and establishing appropriate preventative measures. Out of 48 cleaning verification swab failures, 45 deviation reports lacked an assignable root cause.